Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Jun 21;5(6):e11237.
doi: 10.1371/journal.pone.0011237.

Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment

Affiliations
Clinical Trial

Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment

James M Young et al. PLoS One. .

Abstract

Background: T cells producing multiple factors have been shown to be required for protection from disease progression in HIV but we have recently shown this not to be the case in TB. Subjects with active disease had a greater proportion of polyfunctional cells responding to ESAT-6/CFP-10 stimulation than their infected but non-diseased household contacts (HHC). We therefore wanted to assess this profile in subjects who had successfully completed standard TB chemotherapy.

Methods: We performed a cross-sectional study using PBMC from TB cases (pre- and post-treatment) and HHC. Samples were stimulated overnight with TB antigens (ESAT-6/CFP-10 and PPD) and their CD4+ and CD8+ T cells were assessed for production of CD107a, IFN-gamma, IL-2 and TNF-alpha and the complexity of the responses was determined using SPICE and PESTLE software.

Results and conclusions: We found that an increase in complexity (i.e., production of more than 1 factor simultaneously) of the T cell profile was associated with TB disease and that this was significantly reduced following TB treatment. This implies that T cells are able to respond adequately to TB antigens with active disease (at least initially) but the ability of this response to protect the host from disease progression is hampered, presumably due to immune evasion strategies by the bacteria. These findings have implications for the development of new diagnostics and vaccine strategies.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Representative flow cytometry profiles demonstrating the gating strategy used throughout the study.
A) PBMC were stimulated overnight and cells were analysed by flow cytometry for expression of CD107a, TNF-α, IL-2 and IFN-γ. Following lymphocyte gating, CD4+ and CD8+ T cells were analysed separately for combinations of all 4 factors. B) Representative dot plots illustrating cytokine production from CD4+ and CD8+ T cells following PHA, PPD, EC and no stimulation.
Figure 2
Figure 2. Increased CD107a, IFN-γ and TNF-α expression in TB cases pre-treatment and reduction post-treatment.
Bar indicates median of TB cases pre-treatment (n = 12, filled circles), TB cases post-treatment (n = 10, open circles) and 17 HHC (triangles). Data were analysed using a Kruskal-Wallis ANOVA followed by Dunn's post-test comparison and p-values indicated.
Figure 3
Figure 3. The functional profile of CD4+ and CD8+ T cells is increased in TB cases but reduced post-treatment.
PBMC were stimulated overnight using ESAT-6/CFP-10 and CD4+ and CD8+ cells were analysed by flow cytometry for different combinations of IFN-γ, IL-2, TNF-α and CD107a. Responses are grouped and colour coded according to the number of factors: White  = 1 function, black  =  any 2 factors, blue  =  any 3 factors and red  =  all 4 factors. The pie charts summarise the results shown in the dot plots indicating the combination of cytokines as a percent of total responding cells for CD4+ (A) and CD8+ (B). Significant differences are indicated and were determined using a Kruskal-Wallis ANOVA followed by Dunn's post-test comparison. Pie chart segments were analysed using a permutation test and p-values indicated.

References

    1. 2009. WHO 2008 Tuberculosis Facts. Stop TB partnership pp 1–2. Available at: http://www.who.int/tb/publications/2008/factsheet_april08.pdf. Accessed 25th March, 2009.
    1. Goldsack L, Kirman JR. Half-truths and selective memory: Interferon gamma, CD4+ T cells and protective memory against tuberculosis. Tuberculosis. 2007;87:465–473. - PubMed
    1. Stenger S. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis. 2005;64:24–28. - PMC - PubMed
    1. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107:4781–4789. - PMC - PubMed
    1. Abel B, Tameris M, Mansoor N, et al. The novel TB vaccine, AERAS-402, induces robust and polyfunctional CD4 and CD8 T cells in adults. Am J Respir Crit Care Med. 2010. Feb 18 [Epub ahead of print] - PMC - PubMed

Publication types

MeSH terms